Comparison of non-fasting LDL-C levels calculated by Friedewald formula with those directly measured in Chinese patients with coronary heart disease after a daily breakfast

1988, Arch. Intern. Med., 148, 36, 10.1001/archinte.1988.00380010040006 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001, Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, cholesterol and recurrent events trial investigators, N. Engl. J. Med., 335, 1001, 10.1056/NEJM199610033351401 Shepherd, 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia, west of Scotland coronary prevention study group, N. Engl. J. Med., 333, 1301, 10.1056/NEJM199511163332001 The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group, 1998, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels, N. Engl. J. Med., 339, 1349, 10.1056/NEJM199811053391902 Teramoto, 2016, Efficacy and safety of alirocumab in Japanese patients with heterozygous familial hypercholesterolemia or at high cardiovascular risk with hypercholesterolemia not adequately controlled with statins - ODYSSEY JAPAN randomized controlled trial, Circ. J., 80, 1980, 10.1253/circj.CJ-16-0387 Nordestgaard, 2009, Fasting and nonfasting LDL cholesterol: to measure or calculate?, Clin. Chem., 55, 845, 10.1373/clinchem.2008.123083 NICE Clinical Guideline CG181 Nordestgaard, 2016, Clin. Chem., 62, 930, 10.1373/clinchem.2016.258897 Langsted, 2011, Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study, Clin. Chem., 57, 482, 10.1373/clinchem.2010.157164 Downs, 2015, Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U.S. department of veterans affairs and U.S. department of defense clinical practice guideline, Ann. Intern. Med., 163, 291, 10.7326/M15-0840 Havel, 1955, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest., 34, 1345, 10.1172/JCI103182 Langlois, 2018, Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol, a consensus statement from EAS and EFLM, Clin. Chem., 64, 1006, 10.1373/clinchem.2018.287037 Ramasamy, 2018, Update on the laboratory investigation of dyslipidemias, Clin. Chim. Acta, 479, 103, 10.1016/j.cca.2018.01.015 Nauck, 2002, Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation, Clin. Chem., 48, 236, 10.1093/clinchem/48.2.236 Bachorik, 1995, The National Cholesterol Education Program Working Group on Lipoprotein Measurement, National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary, Clin. Chem., 41, 1414, 10.1093/clinchem/41.10.1414 Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin. Chem., 18, 499, 10.1093/clinchem/18.6.499 Scharnagl, 2001, The Friedewald formula underestimates LDL cholesterol at low concentrations, Clin. Chem. Lab. Med., 39, 426, 10.1515/CCLM.2001.068 Martin, 2013, Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications, J. Am. Coll. Cardiol., 62, 732, 10.1016/j.jacc.2013.01.079 Garoufi, 2017, Comparing calculated LDL-C with directly measured LDL-C in healthy and in dyslipidemic children, Clin. Biochem., 50, 16, 10.1016/j.clinbiochem.2016.05.026 Meeusen, 2014, Validation of a proposed novel equation for estimating LDL cholesterol, Clin. Chem., 60, 1519, 10.1373/clinchem.2014.227710 DeLong, 1986, A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol, The Lipid Research Clinics Prevalence Study, JAMA, 256, 2372, 10.1001/jama.1986.03380170088024 Klop, 2017, Risk of misclassification with a non-fasting lipid profile in secondary cardiovascular prevention, Clin. Chim. Acta, 472, 90, 10.1016/j.cca.2017.07.005 Hong, 2017, Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease, Lipids Health Dis., 16, 7, 10.1186/s12944-017-0410-0 Tian, 2019, Changes in non-fasting concentrations of blood lipids after a daily Chinese breakfast in overweight subjects without fasting hypertriglyceridemia, Clin. Chim. Acta, 490, 147, 10.1016/j.cca.2019.01.004 Zhao, 2017, Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease, Medicine (Baltimore), 96 Tian, 2017, Apolipoprotein o expression in mouse liver enhances hepatic lipid accumulation by impairing mitochondrial function, Biochem. Biophys. Res. Commun., 491, 8, 10.1016/j.bbrc.2017.06.128 Xu, 2010, Evaluation of the lipid lowering ability, anti-inflammatory effects and clinical safety of intensive therapy with Zhibitai, a Chinese traditional medicine, Atherosclerosis, 211, 237, 10.1016/j.atherosclerosis.2010.01.044 Luo, 2017, Apociii enrichment in HDL impairs HDL-mediated cholesterol efflux capacity, Sci. Rep., 7, 2312, 10.1038/s41598-017-02601-7 Zhao, 2004, Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease, Circulation, 110, 915, 10.1161/01.CIR.0000139985.81163.CE Liu, 2003, Xuezhikang decreases serum lipoprotein(a) and c-reactive protein concentrations in patients with coronary heart disease, Clin. Chem., 49, 1347, 10.1373/49.8.1347 Zhao, 2001, Impairment of endothelial function after a high-fat meal in patients with coronary artery disease, Coron. Artery Dis., 12, 561, 10.1097/00019501-200111000-00006 Liu, 2004, Optimal time point to measure postprandial hypertriglyceridemia after a high-fat meal, Chin. J. Endocri. Metabo., 20, 23 Hwang, 2012, Optimal range of triglyceride values to estimate serum low density lipoprotein cholesterol concentration in Korean adults: the Korea National Health and Nutrition Examination Survey, 2009, J. Korean Med. Sci., 27, 1530, 10.3346/jkms.2012.27.12.1530 Mora, 2009, Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27331 women, Clin. Chem., 55, 888, 10.1373/clinchem.2008.117929 Tighe, 2006, Clin. Chim. Acta, 365, 236, 10.1016/j.cca.2005.08.026 Tanno, 2010, Comparison of low-density lipoprotein cholesterol concentrations measured by a direct homogeneous assay and by the Friedewald formula in a large community population, Clin. Chim. Acta, 411, 1774, 10.1016/j.cca.2010.07.034 Varbo, 2013, Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation, Circulation, 128, 1298, 10.1161/CIRCULATIONAHA.113.003008 Sathiyakumar, 2018, Fasting versus nonfasting and low density lipoprotein cholesterol accuracy, Circulation, 137, 10, 10.1161/CIRCULATIONAHA.117.030677 Miller, 2002, Performance of four homogeneous direct methods for LDL-cholesterol, Clin. Chem., 48, 489, 10.1093/clinchem/48.3.489 Martin, 2013, Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile, JAMA, 310, 2061, 10.1001/jama.2013.280532 Langsted, 2008, Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction, Circulation, 118, 2047, 10.1161/CIRCULATIONAHA.108.804146 Nordestgaard, 2017, A test in context: lipid profile, fasting versus nonfasting, J. Am. Coll. Cardiol., 70, 1637, 10.1016/j.jacc.2017.08.006 Catapano, 2016, Atherosclerosis, 253, 281, 10.1016/j.atherosclerosis.2016.08.018 Anderson, 2016, Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult, Can. J. Cardiol., 32, 1263, 10.1016/j.cjca.2016.07.510 Jellinger, 2017, American association of clinical endocrinologists and American college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease, Endocr. Pract., 23, 1, 10.4158/EP171764.APPGL Grundy, 2018